A positron emission tomography (PET) scan is an imaging test that uses a small amount of radioactive tracer to measure the ...

Growing interest in the technology plus a novel tracer on the way may induce change in coming years, says Marcelo Di Carli.

A radioactive tracer combined with a PET-CT scan could replace three different scans and help improve treatment designs for ...

Radiation is part of treatment for about half of cancer patients. A breakthrough could change the future of the treatment.

The states and commonwealth with the longest travel distance for PET were Puerto Rico, Montana and Idaho. The states with the shortest travel distance were New York, Nevada and Arizona. Of 392 major ...

There's no single test that can tell when someone has Alzheimer's disease. Identifying the disease in the early stages allows ...

It is now simpler to differentiate between primary tauopathy and Alzheimer's disease thanks to a novel biomarker.

The company has products for Alzheimer's care that range from diagnosis to treatment monitoring, including MR and PET ...

The US Food and Drug Administration (FDA) has granted fast track designation to Life Molecular Imaging’s (LMI) tau positron ...

In Alzheimer's disease and primary 4-repeat tauopathies, large pathological aggregates of the tau protein are found in the ...

Positron emission tomography, or PET, scans have long been used to diagnose cancer and determine how far it has progressed.